Submitted by Anonymous (not verified) on 19 November 2026 - 9:31
Orphan designation: efgartigimod alfa Treatment of idiopathic inflammatory myopathy, 19/10/2026 Positive
Source:
Orphan designation: efgartigimod alfa Treatment of idiopathic inflammatory myopathy, 19/10/2026 Positive